Phillip Apprill

630 total citations
9 papers, 499 citations indexed

About

Phillip Apprill is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pharmacology. According to data from OpenAlex, Phillip Apprill has authored 9 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pharmacology. Recurrent topics in Phillip Apprill's work include Cardiac Imaging and Diagnostics (5 papers), Cardiovascular Function and Risk Factors (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Phillip Apprill is often cited by papers focused on Cardiac Imaging and Diagnostics (5 papers), Cardiovascular Function and Risk Factors (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Phillip Apprill collaborates with scholars based in United States, Norway and India. Phillip Apprill's co-authors include James T. Willerson, L. Maximilian Buja, J H Ashton, Larry R. Bush, William B. Campbell, Joy M. Schmitz, Michael D. Winniford, Gregory D. Tilton, James M. Schmitz and Thomas C. Smitherman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Phillip Apprill

9 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Apprill United States 8 342 146 111 85 74 9 499
B Haider United States 14 471 1.4× 152 1.0× 79 0.7× 47 0.6× 114 1.5× 29 633
S Jost Germany 8 335 1.0× 158 1.1× 202 1.8× 72 0.8× 81 1.1× 18 589
M M Lyons United States 13 372 1.1× 72 0.5× 101 0.9× 57 0.7× 92 1.2× 23 634
James M. Schmitz United States 9 212 0.6× 60 0.4× 63 0.6× 33 0.4× 69 0.9× 12 362
F Rauscha Austria 10 180 0.5× 41 0.3× 81 0.7× 58 0.7× 40 0.5× 34 350
Kwon Sam Kim South Korea 12 344 1.0× 115 0.8× 148 1.3× 20 0.2× 99 1.3× 52 579
Mitsuhiro Yokota Japan 8 218 0.6× 63 0.4× 108 1.0× 97 1.1× 56 0.8× 11 399
Yoichi Miwa Japan 12 242 0.7× 68 0.5× 158 1.4× 161 1.9× 125 1.7× 18 545
Narisa Futrakul Thailand 15 163 0.5× 39 0.3× 59 0.5× 56 0.7× 121 1.6× 52 657
Shuichi Okamatsu Japan 11 190 0.6× 93 0.6× 79 0.7× 52 0.6× 50 0.7× 28 338

Countries citing papers authored by Phillip Apprill

Since Specialization
Citations

This map shows the geographic impact of Phillip Apprill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Apprill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Apprill more than expected).

Fields of papers citing papers by Phillip Apprill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Apprill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Apprill. The network helps show where Phillip Apprill may publish in the future.

Co-authorship network of co-authors of Phillip Apprill

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Apprill. A scholar is included among the top collaborators of Phillip Apprill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Apprill. Phillip Apprill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Apprill, Phillip, J H Ashton, J. Luis Guerrero, et al.. (1987). Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. American Heart Journal. 113(4). 898–906. 5 indexed citations
2.
Winniford, Michael D., Donald E. Jansen, Gary A. Reynolds, et al.. (1987). Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. The American Journal of Cardiology. 59(4). 203–207. 45 indexed citations
3.
Tilton, Gregory D., L. Maximilian Buja, David W. Bilheimer, et al.. (1985). Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the watanabe heritable hyperlipidemic rabbit: An animal model of familial hypercholesterolemia. Journal of the American College of Cardiology. 6(1). 141–144. 47 indexed citations
4.
Schmitz, Joy M., Phillip Apprill, L. Maximilian Buja, James T. Willerson, & William B. Campbell. (1985). Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.. Circulation Research. 57(2). 223–231. 67 indexed citations
7.
Tilton, Gregory D., Larry R. Bush, Phillip Apprill, L. Maximilian Buja, & James T. Willerson. (1985). Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs.. Circulation. 71(1). 165–175. 20 indexed citations
8.
Bush, Larry R., W B Campbell, Karl B. Kern, et al.. (1984). The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.. Circulation Research. 55(5). 642–652. 92 indexed citations
9.
Willerson, James T., William B. Campbell, Michael D. Winniford, et al.. (1984). Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms. The American Journal of Cardiology. 54(10). 1349–1354. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026